文献速递胃肠动力与功能性疾病

COVID-19大流行前后脑-肠互动障碍(DGBI)患病率与负担变化

The Prevalence and Burden of Disorders of Gut-Brain Interaction (DGBI) Before vs After the COVID-19 Pandemic.
PubMed 文献 · Clin Gastroenterol Hepatol · 2025-07-30

该研究在英美两国开展基于人群的互联网调查,2017年(大流行前,n=4050)与2023年(大流行后,n=4002)重复进行,采用Rome IV诊断问卷。结果显示DGBI总体患病率从38.3%升至42.6%(OR 1.20;95%CI 1.09-1.31),功能性消化不良和肠易激综合征增幅较大,且新冠感染次数、长新冠等因素与DGBI相关。

要点

  • 大流行后DGBI总体患病率显著上升,英美两国结果一致
  • 功能性消化不良和肠易激综合征患病率增幅较大
  • 长新冠患者DGBI负担更重,生活质量更差、就医更多

核心结论

  • COVID-19大流行后DGBI的人群患病率和负担均增加,卫生服务与研究资助需适应这一变化。

研究设计与样本

  • 在英美两国开展基于人群的互联网调查,设预设人口学配额,2017年(大流行前,n=4050)与2023年(大流行后,n=4002)重复进行。
  • 调查包含Rome IV诊断问卷及非胃肠躯体症状、焦虑抑郁、生活质量和医疗利用等问题,2023年调查还包含新冠感染和病史问题。

主要发现

  • DGBI总体患病率从大流行前的38.3%升至大流行后的42.6%(OR 1.20;95%CI 1.09-1.31),英美两国独立分析结果相似。
  • 食管域DGBI患病率从8.8%升至10.1%(OR 1.16),胃十二指肠域从11.9%升至16.4%(OR 1.45),肠道域从30.1%升至32.5%(OR 1.12)。
  • 功能性消化不良患病率从8.3%升至11.9%(OR 1.48),肠易激综合征从4.7%升至6.0%(OR 1.31)。
  • 多变量分析中,大流行后DGBI相关因素包括年轻年龄、女性、焦虑、抑郁、中重度躯体症状、新冠感染次数增加、感染期间腹痛或腹泻、长新冠。
  • 大流行后DGBI患者(尤其长新冠者)生活质量降低、情绪障碍和躯体症状报告及医疗利用高于大流行前DGBI患者。

临床怎么用

  • 消化内科应关注大流行后DGBI患病率上升,对长新冠相关胃肠症状患者进行DGBI评估与管理。
  • 临床需重视DGBI患者合并的焦虑、抑郁及躯体症状,并合理配置医疗资源应对就医需求增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: COVID-19 infection may increase the risk of developing disorders of gut-brain interaction (DGBI). However, the extent of this effect on a population level is poorly understood. We performed a 2-country survey to address this issue. METHODS: A population-based Internet survey with predefined demographic quotas was conducted across the United Kingdom (UK) and United States (U.S.) in 2017 (pre-pandemic; n = 4050) and repeated in 2023 (post-pandemic; n = 4002). The surveys included the Rome IV diagnostic questionnaire, and questions about nongastrointestinal somatic symptoms, anxiety and depression, quality of life, and health care utilization. The 2023 survey also included questions regarding COVID-19 infection and illness history. RESULTS: The overall DGBI prevalence (ie, meeting diagnostic criteria for at least 1 DGBI) has significantly increased from the pre- to post- pandemic era (38.3% vs 42.6%; odds ratio [OR], 1.20; 95% confidence interval, 1.09-1.31), with similar findings independently noted in the UK and U.S. The rise in DGBI was observed within the esophageal (8.8% vs 10.1%; OR, 1.16), gastroduodenal (11.9% vs 16.4%; OR, 1.45), and bowel domains (30.1% vs 32.5%; OR, 1.12). The 2 most widely investigated DGBIs showed large post-pandemic prevalence increases, with functional dyspepsia rising from 8.3% to 11.9% (OR, 1.48) and irritable bowel syndrome from 4.7% to 6.0% (OR, 1.31). In multivariable analysis, factors significantly associated with having DGBI in the post-pandemic era included younger age, female sex, anxiety, depression, medium-to-high somatic symptom severity, increasing number of COVID-19 infections, experiencing abdominal pain or diarrhea during COVID-19 infection, and suffering with long COVID. Individuals with DGBI in the post-pandemic era, in particular those with long COVID, reported reduced quality of life and higher mood disturbances, somatic symptom reporting, and health care use than individuals with DGBI in the pre-pandemic era. CONCLUSIONS: The population prevalence and burden of DGBI have increased following the COVID-19 pandemic. Health care services and research funding bodies need to adapt to this post-COVID rise in DGBI and address how to best manage this patient group.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Palsson O, Simren M, Sperber AD, et al. The Prevalence and Burden of Disorders of Gut-Brain Interaction (DGBI) Before vs After the COVID-19 Pandemic. Clin Gastroenterol Hepatol. 2025. PMID: 40749814. doi:10.1016/j.cgh.2025.07.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。